417 related articles for article (PubMed ID: 22221848)
21. [The treatment of inherited coagulation disorders].
Blombäck M; Nilsson IM
Lakartidningen; 1972 Dec; 69():Suppl 4:76-84. PubMed ID: 4540328
[No Abstract] [Full Text] [Related]
22. Improved kinetics of rIX-FP, a recombinant fusion protein linking factor IX with albumin, in cynomolgus monkeys and hemophilia B dogs.
Nolte MW; Nichols TC; Mueller-Cohrs J; Merricks EP; Pragst I; Zollner S; Dickneite G
J Thromb Haemost; 2012 Aug; 10(8):1591-9. PubMed ID: 22726310
[TBL] [Abstract][Full Text] [Related]
23. Bringing new therapy options to the hemophilia community.
Bensen-Kennedy D
Thromb Res; 2013 Mar; 131 Suppl 2():S15-8. PubMed ID: 23537722
[TBL] [Abstract][Full Text] [Related]
24. Real-World Utilisation and Bleed Rates in Patients with Haemophilia B Who Switched to Recombinant Factor IX Fusion Protein (rIX-FP): A Retrospective International Analysis.
Hermans C; Marino R; Lambert C; Mangles S; Sommerer P; Rives V; Maro G; Malcangi G
Adv Ther; 2020 Jun; 37(6):2988-2998. PubMed ID: 32333327
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive care for hemophilia and other inherited bleeding disorders.
Page D
Transfus Apher Sci; 2019 Oct; 58(5):565-568. PubMed ID: 31427262
[TBL] [Abstract][Full Text] [Related]
26. Guidelines on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders.
United Kingdom Haemophelia Centre Doctors' Organisation
Haemophilia; 2003 Jan; 9(1):1-23. PubMed ID: 12558775
[TBL] [Abstract][Full Text] [Related]
27. Acquired haemophilia in association with type III von Willebrand's disease: successful treatment with high purity von Willebrand's factor and recombinant factor VIIa.
Majumdar G; Phillips JK; Lavallee H; Savidge GF
Blood Coagul Fibrinolysis; 1993 Dec; 4(6):1035-7. PubMed ID: 8148477
[TBL] [Abstract][Full Text] [Related]
28. Thrombin generation and fibrinolysis in anti-factor IX treated blood and plasma spiked with factor VIII inhibitor bypassing activity or recombinant factor VIIa.
Bolliger D; Szlam F; Molinaro RJ; Escobar MA; Levy JH; Tanaka KA
Haemophilia; 2010 May; 16(3):510-7. PubMed ID: 20050927
[TBL] [Abstract][Full Text] [Related]
29. Recent advances in surgery and its perioperative treatment in people with hemophilia.
Rodríguez-Merchán EC
Expert Rev Hematol; 2021 Mar; 14(3):271-280. PubMed ID: 33605827
[No Abstract] [Full Text] [Related]
30. Drug therapy reviews: clinical use of hemostatic agents.
Lowe GD; Lawson DH
Am J Hosp Pharm; 1978 Apr; 35(4):414-22. PubMed ID: 306196
[TBL] [Abstract][Full Text] [Related]
31. Clinical uses of plasma and plasma fractions: plasma-derived products for hemophilias A and B, and for von Willebrand disease.
Josephson CD; Abshire TC
Best Pract Res Clin Haematol; 2006; 19(1):35-49. PubMed ID: 16377540
[TBL] [Abstract][Full Text] [Related]
32. Recombinant blood clotting proteins for hemophilia therapy.
Limentani SA; Roth DA; Furie BC; Furie B
Semin Thromb Hemost; 1993; 19(1):62-72. PubMed ID: 8456325
[No Abstract] [Full Text] [Related]
33. Development of long-acting recombinant FVIII and FIX Fc fusion proteins for the management of hemophilia.
Shapiro A
Expert Opin Biol Ther; 2013 Sep; 13(9):1287-97. PubMed ID: 23930915
[TBL] [Abstract][Full Text] [Related]
34. Advances in clotting factor treatment for congenital hemorrhagic disorders.
Tarantino MD; Aledort LM
Clin Adv Hematol Oncol; 2004 Jun; 2(6):363-8. PubMed ID: 16163206
[TBL] [Abstract][Full Text] [Related]
35. Recombinant factor VIIa: a universal hemostatic agent?
Lloyd JV; Joist JH
Curr Hematol Rep; 2002 Sep; 1(1):19-26. PubMed ID: 12901121
[TBL] [Abstract][Full Text] [Related]
36. Surgical care of patients with hereditary disorders of blood coagulation.
Shulman NR
Mod Treat; 1968 Jan; 5(1):61-83. PubMed ID: 4870180
[No Abstract] [Full Text] [Related]
37. Coagulation Factor IX (Recombinant), Albumin Fusion Protein (Albutrepenonacog Alfa; Idelvion
Lyseng-Williamson KA
Drugs; 2017 Jan; 77(1):97-106. PubMed ID: 27988873
[TBL] [Abstract][Full Text] [Related]
38. The challenge arising from the cost of haemophilia care: an audit of haemophilia treatment at Auckland Hospital.
Harper P; Brasser M; Moore L; Teague L; Pitcher L; Ockelford P
N Z Med J; 2003 Aug; 116(1180):U561. PubMed ID: 14581983
[TBL] [Abstract][Full Text] [Related]
39. Biodistribution of the recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in rats.
Herzog E; Harris S; Henson C; McEwen A; Schenk S; Nolte MW; Pragst I; Dickneite G; Schulte S; Zollner S
Thromb Res; 2014 May; 133(5):900-7. PubMed ID: 24680550
[TBL] [Abstract][Full Text] [Related]
40. [Treatment and prevention of haemorrhage with recombinant activated factor VII, not only in hemophilia].
Levi M; Friederich PW; van der Meer J
Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2534-7. PubMed ID: 12532665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
